The new service line seeks to connect fertility to comprehensive women’s healthcare with unbiased counseling, prevention-focused care, and mental health support The women’s healthcare start-up also released its first brand campaign called “Trying” questioning the social pressure put on women in their fertility journeys & choices NEW YORK–(BUSINESS WIRE)–Tia, the modern medical home for women, … [Read more…]
– ANNOVERA is the only FDA-approved procedure-free, long-lasting, reversible birth control – – With this approval, the Company expects a significant reduction in its manufacturing batch rejections and an increase in future product supply and will enable the Company to better meet short- and long-term customer demand – BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” … [Read more…]
CHICAGO–(BUSINESS WIRE)–Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce it has completed a partnership with AA Medical, a provider of sustainable solutions to both the new and resale medical device equipment markets based in Mokena, Illinois, with a second location in Miami, Florida. AA Medical was founded in 2012 by Ron Plantz … [Read more…]
SAN DIEGO & VANCOUVER, British Columbia–(BUSINESS WIRE)–Tentarix Biotherapeutics LP, a biotechnology company developing first-in-class targeted, conditional antibody-based multifunctional biotherapies, today announced the formation of a Scientific Advisory Board (SAB) and appointments to its Board of Directors and leadership team. The SAB, initially comprised of three experts in immunology, cancer biology and protein engineering, will provide … [Read more…]
Heart Failure 2022 Presentation Includes Preclinical Data Supporting TN-301 Effect in HFpEF Models TN-301 IND Submission on Track for Second Half of 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced that … [Read more…]
Opinion granted based on positive results from the Phase 3 KEYNOTE-716 trial If approved, KEYTRUDA would be the first anti-PD-1 immunotherapy treatment option for patients 12 years and older in the EU across stage IIB, IIC and III melanoma following complete resection RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Dr. Philip S. Low, a renowned targeted drug discovery researcher and veteran biotech entrepreneur, to the company’s Board of Directors. “In conjunction with today’s acquisition … [Read more…]
Merz Aesthetics logo will be featured on lower back of NC Courage home and away jerseys through 2023 Sponsor of community programs to encourage confidence, character and sportsmanship among local teenage girls RALEIGH, N.C.–(BUSINESS WIRE)–Merz Aesthetics, the world’s largest dedicated medical aesthetics business, is pleased to kick off a new partnership with the North Carolina … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company developing therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the completion of its acquisition of Novosteo, a privately-held biotech company focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury. Novosteo stockholders now own … [Read more…]
Development of Exodus Algorithm Overcomes Limitations in Identifying and Quantifying the Genomes of Genetically Related Microorganisms BRANFORD, Conn. & NESS ZIONA, Israel–(BUSINESS WIRE)–BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the publication of a scientific paper … [Read more…]
